|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Three-dimensional esophageal varix model quantification of variceal volume by high-resolution endoluminal US显示文摘 | Chung CY McCray WH Dhaliwal S | | 0，，： | 1 |
| 2 | Acupuncture for Chronic Knee PainA Randomized Clinical Tria! 显示文摘 | Ratia S Hinmari Paul McCray | 2014 | JAMA2014，312，13： | 1 |
| 3 | Gene therapy progress and pros- pects: development of improved lentiviral and retroviral vectors: de- sign, biosafety, and production显示文摘 | Sinn P L Sauter S L McCray P B | 2005 | Gene Ther2005，12，14： | 1 |
| 4 | Engineered streambeds for induced hyporheic flow: enhanced removal of nutrients, pathogens, and metals from Urban streams 显示文摘 | Herzog S P Higgins C P McCray J E | 2015 | Journal of Environmental Engineering2015，142，04： | 1 |
| 5 | Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyI pepti- dase4显示文摘 | Li K Wohlford-Lenane C Perlman S Zhao J Jewell A K Reznikov L R Gibson-Corley K N Meyerholz D K McCray P B Jr | 2016 | J Infect Dis2016，213，5： | 1 |
| 6 | Gene therapy progress and prospects:development of improved of lentiviral and retroviral vectors-design,biosafety,and production显示文摘 | SINN P L SAUTER S L MCCRAY P B | 2005 | Gene Ther2005，12，14： | 1 |
| 7 | Human beta-defensins 2 and 3 demonstrate strain -selective activity against oral microorganisms显示文摘 | Joly S Maze C McCray PB Jr | 2004 | J Clin Microbiol2004，42，3： | 1 |
| 8 | Human beta - defensins 2 and 3 demonstrate strain - selective activity against oral microorganisms 显示文摘 | Joly S Maze C McCray PB Jr | 2004 | Clin Microbiol2004，42，3： | 1 |
| 9 | Weeekly luteal- phase dosing with enteric - coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double - blind, placebocontrolled clinical trial显示文摘 | Brown E McCray S | 2002 | Clin Ther2002，24，3： | 1 |
| 10 | Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms显示文摘 | Joly S Maze C McCray PB Jr | 2004 | J Clin Microbiol2004，42，3： | 1 |
| 11 | Genetherapy progress and prospects: development of improved lentiviral and retroviral vectors design, biosaftey and production显示文摘 | Sinn P L Santer S L McCray P B Jr | 2005 | Gene Ther2005，12，14： | 1 |
| 12 | Gene therapy progressand prospects: development of improved lentiviral and retrovi-ral vectors-design, biosafety, and production显示文摘 | Sinn P L Sauter S L McCray P B Jr | 2005 | Gene Ther2005，12，14： | 1 |
| 13 | Person-to-person spread of the MERS coronavirus-an evolving picture显示文摘 | Perlman S McCray PB Jr | 2013 | N Engl J Med2013，369，5： | 1 |
| 14 | Human beta- defensins 2 and 3 demonstrate strain - selective activity against oral microorganisms 显示文摘 | Joly S Maze C McCray PB Jr | 2004 | J Clin Microbiol2004，42，3： | 1 |
| 15 | Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms显示文摘 | Joly S Maze C McCray PB Jr | | 0，，03： | 1 |
| 16 | Weekly luteal-phasedosing with enteric-coated fluoxetine 90 mg in premenstru-aldysphoric disorder: a randomized, double -blind, place-bo-controlled clinicaltrial显示文摘 | Miner C Brown E McCray S | 2002 | Clin Ther2002，24，3： | 1 |
| 17 | Rapid generation of a mouse model for Middle East respiratory syndrome显示文摘 | Zhao J Li K Wohlford-Lenane C Agnihothram S S Fett C Zhao J Gale M J Jr Baric R S Enjuanes L Gallagher T McCray P B Jr Perlman S | | Proc Natl Acad Sci0，2111，13： | 1 |
| 18 | Human β-defensin 2 and 3 demonstrate strain-selective activity against oral microorganisms显示文摘 | JOLY S MAZE C MCCRAY P | 2004 | J Clin Microbiol2004，42，3： | 1 |
| 19 | Gene therapy progress and prospects,development of improved of lentiviral and retrovira vectors- desfgn,biosafety, and production显示文摘 | Sinn PL Sauter S L Mccray PB | 2005 | Geee Ther2005，12，14： | 1 |
| 20 | Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms显示文摘 | JOLY S MAZE C MCCRAY P B | 2004 | J Clin Microbiol2004，42，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员